SCHEMBL9901289

SCHEMBL9901289

N#Cc1cc(CCc2ncc(Cc3cncnc3)c(=O)[nH]2)ccc1Oc1ccc(Cl)c(C(F)(F)F)c1

nearest known ligand 0.60

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PLA2G7 Q13093 15/20 0.60
AR P10275 3/20 0.39
SLC22A12 Q96S37 1/20 0.38
KDR P35968 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9901506 0.89 PLA2G7 (0.57) PLA2G7
SCHEMBL9900408 0.88 PLA2G7 (0.56) PLA2G7AR
SCHEMBL9106950 0.85 PLA2G7 (0.50) PLA2G7AR
SCHEMBL9900555 0.81 PLA2G7 (0.47) PLA2G7AR
SCHEMBL9900795 0.81 PLA2G7 (0.48) PLA2G7ARKDR
SCHEMBL9901101 0.80 PLA2G7 (0.53) PLA2G7ARSLC22A12
SCHEMBL9900710 0.79 PLA2G7 (0.47) PLA2G7AR
SCHEMBL9103235 0.78 PLA2G7 (0.48) PLA2G7AR
SCHEMBL9900816 0.78 PLA2G7 (0.47) PLA2G7AR
SCHEMBL9105050 0.78 PLA2G7 (0.46) PLA2G7ARSLC22A12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2649053-A1 PYRIMIDINONE COMPOUNDS FOR USE IN THE TREATMENT OF DISEASES OR CONDITIONS MEDIATED BY LP - PLA2 Glaxo Group Limited (GB) 2013-10-16 EP disclosed
WO-2012076435-A1 PYRIMIDINONE COMPOUNDS FOR USE IN THE TREATMENT OF DISEASES OR CONDITIONS MEDIATED BY LP - PLA2 GLAXO GROUP LIMITED (GB) 2012-06-14 WO disclosed